StoneX Group’s Medpace MEDP Stock Holding History

StoneX Group’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-517	Closed	-$266K	–	1160
2025 Q3	$266K	Buy	+517	New	+$226K	0.01%	734

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

StoneX Group's MEDP Position: Q4 2025 in Review

StoneX Group sold out of Medpace (MEDP) in Q4 2025, closing a stake of 517 shares — an estimated $266K sold.

StoneX Group first reported a position in MEDP in Q3 2025 and held it in 1 quarter. The position peaked at $266K in Q3 2025. 785 funds tracked by Wall St. Rank hold MEDP as of Q4 2025.

StoneX Group reported no remaining Medpace position as of Q4 2025 after selling out during the quarter.
StoneX Group sold 517 Medpace shares in Q4 2025, an estimated $266K.
StoneX Group first reported a position in Medpace in Q3 2025 and held it in 1 quarter.
StoneX Group's Medpace position peaked at $266K in Q3 2025.
785 funds tracked by Wall St. Rank held Medpace as of Q4 2025.

Based on StoneX Group's 13F filing for Q4 2025, filed 12 Feb 2026.